ACTH as first line treatment for acute calcium pyrophosphate crystal arthritis in 14 hospitalized patients

Joint Bone Spine

Volumn 81, Issue 1, 2014, Pages 98-100

  Daoussis, Dimitrios ^a   Antonopoulos, Ioannis ^a   Yiannopoulos, Georgios ^a   Andonopoulos, Andrew P ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

ACTH; Acute CPP crystal arthritis; Calcium pyrophosphate; Crystal induced arthritis; Pseudo gout; Treatment

Indexed keywords

CORTICOTROPIN; GLUCOSE; POTASSIUM; STEROID; ANTIINFLAMMATORY AGENT;

AGED; CALCIUM PYROPHOSPHATE CRYSTAL ARTHRITIS; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONAL THERAPY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LETTER; MALE; POTASSIUM BLOOD LEVEL; PSEUDOGOUT; RETROSPECTIVE STUDY; STEROID RELEASE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TREATMENT RESPONSE; VERY ELDERLY; ACUTE CALCIUM PYROPHOSPHATE DIHYRATE CRYSTAL ARTHRITIS; ARTHRITIS; CHONDROCALCINOSIS;

ADRENOCORTICOTROPIC HORMONE; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; CHONDROCALCINOSIS; FEMALE; HOSPITALIZATION; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 84893734157     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.05.006     Document Type: Letter

References (10)

1. Zhang W., Doherty M., Pascual E., et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis 2011, 70:571-575.
2. Getting S.J., Christian H.C., Flower R.J., et al. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 2002, 46:2765-2775.
3. Getting S.J., Gibbs L., Clark A.J., et al. POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. J Immunol 1999, 162:7446-7453.
4. Montero-Melendez T., Patel H.B., Perretti M. Role of melanocortin receptors in the regulation of gouty inflammation. Curr Rheumatol Rep 2011, 13:138-145.
5. Capsoni F., Ongari A.M., Reali E., et al. Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells. Arthritis Res Ther 2009, 11:R151.
6. Getting S.J., Lam C.W., Chen A.S., et al. Melanocortin 3 receptors control crystal-induced inflammation. FASEB J 2006, 20:2234-2241.
7. Daoussis D., Antonopoulos I., Yiannopoulos G., et al. ACTH as first line treatment for acute gout in 181 hospitalized patients. Joint Bone Spine 2012, 10.1016/j.jbspin.2012.09.009.
8. Ritter J., Kerr L.D., Valeriano-Marcet J., et al. ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems. J Rheumatol 1994, 21:696-699.
9. Moltó A., Ea H.K., Richette P., et al. Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis. Joint Bone Spine 2012, 79:621-623.
10. Ottaviani S., Brunier L., Sibilia J., et al. Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: A report of 16 cases and review of the literature. Joint Bone Spine 2013, 80:178-182.